PANUNZIO, ANDREA
 Distribuzione geografica
Continente #
EU - Europa 2.440
NA - Nord America 2.262
AS - Asia 1.882
SA - Sud America 349
AF - Africa 138
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.076
Nazione #
US - Stati Uniti d'America 2.168
RU - Federazione Russa 1.311
SG - Singapore 758
IT - Italia 443
CN - Cina 362
BR - Brasile 289
HK - Hong Kong 207
VN - Vietnam 207
GB - Regno Unito 117
BD - Bangladesh 87
DE - Germania 84
FI - Finlandia 84
IE - Irlanda 71
NL - Olanda 70
SE - Svezia 69
KR - Corea 59
FR - Francia 57
CA - Canada 54
TG - Togo 42
IN - India 35
TR - Turchia 28
ES - Italia 25
PL - Polonia 25
IQ - Iraq 24
JP - Giappone 24
BJ - Benin 20
MX - Messico 20
NG - Nigeria 20
AR - Argentina 18
LT - Lituania 16
AT - Austria 15
PK - Pakistan 14
ZA - Sudafrica 14
MA - Marocco 11
UA - Ucraina 11
VE - Venezuela 11
BE - Belgio 10
ID - Indonesia 10
EG - Egitto 9
SA - Arabia Saudita 9
UZ - Uzbekistan 8
TN - Tunisia 7
CO - Colombia 6
CR - Costa Rica 6
EC - Ecuador 6
PH - Filippine 6
PY - Paraguay 6
AZ - Azerbaigian 5
ET - Etiopia 5
JO - Giordania 5
KE - Kenya 5
BO - Bolivia 4
GR - Grecia 4
KG - Kirghizistan 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
CH - Svizzera 3
CL - Cile 3
CY - Cipro 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
HN - Honduras 3
IL - Israele 3
LV - Lettonia 3
AL - Albania 2
AU - Australia 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
LA - Repubblica Popolare Democratica del Laos 2
MY - Malesia 2
NI - Nicaragua 2
NO - Norvegia 2
NP - Nepal 2
PA - Panama 2
PT - Portogallo 2
RO - Romania 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
BF - Burkina Faso 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CU - Cuba 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
GP - Guadalupe 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
IM - Isola di Man 1
IR - Iran 1
JM - Giamaica 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
MK - Macedonia 1
NA - Namibia 1
NZ - Nuova Zelanda 1
Totale 7.068
Città #
Moscow 474
Singapore 465
Ashburn 393
San Jose 302
Dallas 256
Hong Kong 202
Verona 110
Los Angeles 106
New York 105
Beijing 100
The Dalles 90
Chandler 83
Dublin 71
Ho Chi Minh City 70
Hanoi 55
Helsinki 51
Council Bluffs 44
Lomé 42
London 37
Milan 35
São Paulo 34
Buffalo 28
Rome 28
Orem 26
Santa Clara 26
Munich 25
Amsterdam 24
Redondo Beach 23
Frankfurt am Main 22
Montreal 22
Turku 21
Cotonou 20
Abuja 19
Boardman 19
Seattle 19
Warsaw 19
Tokyo 18
Brooklyn 17
Stockholm 16
Chicago 15
Phoenix 15
Columbus 14
Johannesburg 13
Toronto 13
Southend 12
Atlanta 11
Houston 11
Lappeenranta 11
Palermo 11
Bari 10
Bologna 10
Brussels 10
Chennai 10
Jacksonville 10
Manchester 10
Poplar 10
Baghdad 9
Denver 9
San Francisco 9
Cairo 8
Da Nang 8
Guangzhou 8
Lawrence 8
Princeton 8
Rio de Janeiro 8
Ankara 7
Belo Horizonte 7
Redmond 7
Tashkent 7
Washington 7
Dhaka 6
Falkenstein 6
Haiphong 6
Jinan 6
Nuremberg 6
Ottawa 6
Roubaix 6
Vienna 6
Wilmington 6
Amman 5
Ann Arbor 5
Baku 5
Barnet 5
Biên Hòa 5
Bắc Ninh 5
City of London 5
Isola della Scala 5
Mexico City 5
Miami 5
Mumbai 5
Paris 5
San José 5
Sindelfingen 5
São Bernardo do Campo 5
Tianjin 5
Addis Ababa 4
Bexley 4
Bishkek 4
Charlotte 4
Curitiba 4
Totale 3.977
Nome #
The 2012 Briganti nomogram predicts disease progression in surgically treated intermediate-risk prostate cancer patients with favorable tumor grade group eventually associated with some adverse factors 338
Abdominal-aortic atherosclerotic plaque index and perioperative outcomes in partial nephrectomy 205
Advanced age portends poorer prognosis after radical prostatectomy: a single center experience 185
Impairment in Activities of Daily Living Assessed by the Barthel Index Predicts Adverse Oncological Outcomes After Radical Cystectomy for Bladder Cancer 184
Endogenous testosterone density predicts unfavorable disease at final pathology in intermediate risk prostate cancer 184
Advanced age is an independent prognostic factor of disease progression in high-risk prostate cancer: results in 180 patients treated with robot-assisted radical prostatectomy and extended pelvic lymph node dissection in a tertiary referral center 180
Positive Association between Basal Total Testosterone Circulating Levels and Tumor Grade Groups at the Time of Diagnosis of Prostate Cancer 166
The Influence of Endogenous Testosterone Density on Unfavorable Disease and Tumor Load at Final Pathology in Intermediate-Risk Prostate Cancer: Results in 338 Patients Treated with Radical Prostatectomy and Extended Pelvic Lymph Node Dissection 158
Endogenous testosterone density is an independent predictor of pelvic lymph node invasion in high-risk prostate cancer: results in 201 consecutive patients treated with radical prostatectomy and extended pelvic lymph node dissection 157
Searching the half-full glass of COVID-19 pandemic: basic hygienic measures positively impact on postoperative infections after major elective urological surgery: a single-center matched pair analysis 151
Open approach, extended pelvic lymph node dissection, and seminal vesicle invasion are independent predictors of hospital readmission after prostate cancer surgery: A large retrospective study 151
Incidental prostate cancer after transurethral resection of the prostate: analysis of incidence and risk factors in 458 patients 151
Preoperative endogenous total testosterone predicts prostate cancer progression: results in 580 consecutive patients treated with robot assisted radical prostatectomy for clinically localized disease 150
Prognostic Impact and Clinical Implications of Unfavorable Upgrading in Low-Risk Prostate Cancer after Robot-Assisted Radical Prostatectomy: Results of a Single Tertiary Referral Center 149
AB0 blood groups and oncological and functional outcomes in bladder cancer patients treated with radical cystectomy 148
Preoperative endogenous testosterone density predicts disease progression from localized impalpable prostate cancer presenting with PSA levels elevated up to 10 ng/mL 146
American Society of Anesthesiologists (ASA) physical status system predicts the risk of postoperative Clavien-Dindo complications greater than one at 90 days after robot-assisted radical prostatectomy: final results of a tertiary referral center 143
Prostate Volume Index Is Able to Differentiate between Prostatic Chronic Inflammation and Prostate Cancer in Patients with Normal Digital Rectal Examination and Prostate-Specific Antigen Values <10 ng/mL: Results of 564 Biopsy Naïve Cases 142
Clinical implications of endogenous testosterone density on prostate cancer progression in patients with very favorable low and intermediate risk treated with radical prostatectomy 141
The impact of extended pelvic lymph node dissection on the risk of hospital readmission within 180 days after robot assisted radical prostatectomy 140
Gender-specific counselling of patients with upper tract urothelial carcinoma and Lynch syndrome 135
Normal preoperative endogenous testosterone levels predict prostate cancer progression in elderly patients after radical prostatectomy 135
Accuracy of the CUETO, EORTC 2016 and EAU 2021 scoring models and risk stratification tables to predict outcomes in high-grade non-muscle-invasive urothelial bladder cancer 135
The Impact of Baseline Endogenous Testosterone Levels on Risk Stratification in Pathological Organ-Confined Prostate Cancer: Results in 460 Patients Treated with Robot-Assisted Radical Prostatectomy 127
Botulinum Toxin-A Injection in Chronic Pelvic Pain Syndrome Treatment: A Systematic Review and Pooled Meta-Analysis 126
Impact of functional impairment and cognitive status on perioperative outcomes and costs after radical cystectomy: The role of Barthel Index 125
Endogenous testosterone density associates with predictors of tumor upgrading and disease progression in the low through favorable intermediate prostate cancer risk categories: analysis of risk factors and clinical implications 125
Changes in renal function after nephroureterectomy for upper urinary tract carcinoma: analysis of a large multicenter cohort (Radical Nephroureterectomy Outcomes (RaNeO) Research Consortium) 120
Omics in urology: An overview on concepts, current status and future perspectives 120
African American vs Caucasian race/ethnicity in adrenocortical carcinoma patients 118
Transperineal Laser Ablation for Benign Prostatic Enlargement: A Systematic Review and Pooled Analysis of Pilot Studies 115
Cancer-specific Mortality After Cryoablation vs Heat-based Thermal Ablation in T1a Renal Cell Carcinoma 111
Cancer-specific mortality free survival rates in non-metastatic non-clear cell renal carcinoma patients at intermediate/high risk of recurrence 111
Tumor upgrading among very favorable intermediate-risk prostate cancer patients treated with robot-assisted radical prostatectomy: how can it impact the clinical course? 109
Age represents the main driver of surgical decision making in patients candidate to radical cystectomy 101
Differences in Cancer-Specific Mortality after Trimodal Therapy for T2N0M0 Bladder Cancer according to Histological Subtype 100
Racial/ethnic disparities in the distribution and effect of type and number of high-risk criteria on mortality in prostate cancer patients treated with radiotherapy 99
Contemporary conditional cancer-specific survival rates in surgically treated adrenocortical carcinoma patients: A stage-specific analysis 98
Prognostic Impact and Clinical Implications of Adverse Tumor Grade in Very Favorable Low- and Intermediate-Risk Prostate Cancer Patients Treated with Robot-Assisted Radical Prostatectomy: Experience of a Single Tertiary Referral Center 97
Severe systemic disease of the American Society of Anesthesiologists' (ASA) physical status system classification associated with delayed length of hospital stay in 1329 consecutive patients treated with radical prostatectomy for clinical prostate cancer 96
Effect of inguinal lymph node dissection in lymph node negative patients with squamous cell carcinoma of the penis 91
Cancer specific mortality in patients with collecting duct vs. clear cell renal carcinoma 91
Radical cystectomy in non-metastatic sarcomatoid bladder cancer: A direct comparison vs urothelial bladder cancer 91
Collecting duct carcinoma: Epidemiology, clinical characteristics and survival 90
The effect of chemotherapy in sarcomatoid bladder cancer patients treated with radical cystectomy 87
Conditional survival after radical cystectomy for non-metastatic muscle-invasive squamous cell carcinoma of the urinary bladder: A population-based analysis 87
Differences in overall survival between clear cell metastatic renal cell carcinoma patients versus population-based controls according to race/ethnicity in the United States 84
Regional differences in total hospital costs for radical cystectomy in the United States 83
MRI-Derived Apparent Diffusion Coefficient of Peri-Prostatic Adipose Tissue Is a Potential Determinant of Prostate Cancer Aggressiveness in Preoperative Setting: A Preliminary Report 82
Differences in overall survival of T2N0M0 bladder cancer patients vs. population-based controls according to treatment modalities 78
Survival of Testicular Pure Embryonal Carcinoma vs. Mixed Germ Cell Tumor Patients across All Stages 77
Effect of positive surgical margins at radical prostatectomy on cancer-specific mortality in high/very high-risk prostate cancer patients with Gleason Grade Group 4-5 74
Index Cancer Density Is a Stronger Predictor of Pelvic Lymph Node Invasion than Percentage of Biopsy-Positive Cores in EAU High-Risk Prostate Cancer: Clinical Impact in 254 Patients Treated and Staged with Robot-Assisted Radical Prostatectomy 68
The association of type and number of high-risk criteria with cancer-specific mortality in prostate cancer patients treated with radical prostatectomy 66
Mortality According to Treatment in Metastatic Collecting Duct Renal Cell Carcinoma 65
Hispanic vs. Caucasian Race/Ethnicity in Adrenocortical Carcinoma Patients 64
Differences in Survival of Clear Cell Metastatic Renal Cell Carcinoma According to Partial vs. Radical Cytoreductive Nephrectomy 60
Survival of Testicular Pure Teratoma vs. Mixed Germ Cell Tumor Patients in Primary Tumor Specimens across All Stages 53
Effect of race/ethnicity on survival in surgically treated intermediate/high risk non-metastatic clear cell renal carcinoma 52
Is the Barthel index a valid tool for patient selection before urological surgery? A systematic review 24
The Role of Near-Infrared Fluorescence with Indocyanine Green in Robot-Assisted Partial Nephrectomy: Results from an Updated Systematic Review and Meta-Analyses of Controlled Studies 18
Regional differences in stage distribution and rates of treatment for adrenocortical carcinoma across United States SEER registries 16
Totale 7.173
Categoria #
all - tutte 28.450
article - articoli 28.450
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.900


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202272 4 9 1 11 5 1 3 7 2 2 12 15
2022/2023382 13 24 15 45 30 85 25 53 42 5 25 20
2023/2024618 29 41 52 71 42 92 42 25 6 73 74 71
2024/20251.459 75 59 138 194 66 75 117 107 134 119 117 258
2025/20264.570 260 208 264 765 1.225 283 453 229 358 301 75 149
Totale 7.173